Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online before print January 25, 2008, 10.1148/radiol.2463062155
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow AVI Movie
Right arrow All Versions of this Article:
2463062155v1
246/3/917    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Delfino, J. G.
Right arrow Articles by Oshinski, J. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Delfino, J. G.
Right arrow Articles by Oshinski, J. N.
(Radiology 2008;246:917-925.)
© RSNA, 2008


Technical Developments

Three-directional Myocardial Phase-Contrast Tissue Velocity MR Imaging with Navigator-Echo Gating: In Vivo and in Vitro Study1

Jana G. Delfino, PhD, Kevin R. Johnson, PhD, Robert L. Eisner, PhD, Susan Eder, RT, Angel R. Leon, MD, and John N. Oshinski, PhD

1 From the Department of Biomedical Engineering, Georgia Institute of Technology/Emory University, 101 Woodruff Cir, Suite 2001, Atlanta, GA 30322 (J.G.D., K.R.J., J.N.O.); and Departments of Radiology (R.L.E., J.N.O.) and Medicine, Division of Cardiology (S.E., A.R.L.), Emory University School of Medicine, Atlanta, Ga. Received December 18, 2006; revision requested February 16, 2007; revision received March 23; accepted April 25; final version accepted August 1. Supported by the Wallace H. Coulter Foundation. Address correspondence to J.G.D. (e-mail: jana.delfino{at}gatech.edu).

The study protocol was HIPAA compliant and institutional review board approved. Informed consent was obtained from all participants. The purpose of the study was to prospectively validate the capability of navigator-echo–gated phase-contrast magnetic resonance (MR) imaging for measurement of myocardial velocities in a phantom and to prospectively use the phase-contrast MR sequence to measure three-directional velocity in the myocardium in vivo in volunteers and in patients scheduled for cardiac resynchronization therapy. An excellent correlation between the measured velocity and the true phantom motion (R = 0.90 for longitudinal velocity, R = 0.93 for circumferential velocity) was observed. Myocardial velocities were successfully measured in 17 healthy volunteers (11 male, six female; mean age, 27.5 years ± 6.5 [standard deviation]) and 28 patients with heart failure (18 male, 10 female; mean age, 63.9 years ± 15.0). Velocity values were significantly lower in the patients than in the volunteers. The time to peak velocity in the lateral wall of the patients, as compared with that in the volunteers, was delayed. Phase-contrast MR imaging can be combined with navigator-echo gating to measure three-directional myocardial tissue velocities in vivo.

Supplemental material: http://radiology.rsnajnls.org/cgi/content/full/2463062155/DC1

© RSNA, 2008







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 2008 by the Radiological Society of North America.